1. Novel benzimidazole-based MCH R1 antagonists.
- Author
-
Carpenter AJ, Al-Barazanji KA, Barvian KK, Bishop MJ, Britt CS, Cooper JP, Goetz AS, Grizzle MK, Hertzog DL, Ignar DM, Morgan RO, Peckham GE, Speake JD, and Swain WR
- Subjects
- Animals, Benzimidazoles pharmacokinetics, Biological Availability, Body Composition, Dose-Response Relationship, Drug, Mice, Models, Animal, Structure-Activity Relationship, Weight Loss drug effects, Benzimidazoles pharmacology, Obesity drug therapy, Receptors, Somatostatin antagonists & inhibitors
- Abstract
The identification of an MCH R1 antagonist screening hit led to the optimization of a class of benzimidazole-based MCH R1 antagonists. Structure-activity relationships and efforts to optimize pharmacokinetic properties are detailed along with the demonstration of the effectiveness of an MCH R1 antagonist in an animal model of obesity.
- Published
- 2006
- Full Text
- View/download PDF